Identification of a New Hexenoic Acid Glycoside and the RSV Principles from Vitis vinifera cv. Muscat of Alexandria

摘要

Respiratory syncytial virus (RSV) is the most common worldwide cause of lower respiratory tract infections (LRI) in infants, elderly people, and immune-compromised individuals. RSV can be reinfected and previous infection does not prevent subsequent re-infection, but there is no effective vaccine against RSV. Ribavirin has been approved as an antiviral agent against RSV infection, however, its efficacy and clinical benefits are still controversial.